- Latest week
- 10 Jul 2026
- Close
- 9490.000000
- Fair value
- 9467.808390
- Next-week expectancy
- Undecided 54.84%
PFE Chart Pack
Pfizer Inc.
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, PFE fell 6.04%, moving from 10,099.89 to 9,490.00. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 3 of the last 12 weeks. Relative Strength is -20.17 and has softened across the 12-week window. Market Dynamics is -0.95 on the latest week. Next-week expectancy is undecided at 54.84% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 9,490.00
- 12-Week Change
- -6.04%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 54.84%
- Signal Weeks
- 3 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- -20.17
- Market Dynamics
- -0.95
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 9,490.00
- 12-Week Change
- -6.04%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 54.84%
- Signal Weeks
- 3 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- -20.17
- Market Dynamics
- -0.95
Over the latest 12 completed weeks ending 2026-07-10, PFE fell 6.04%, moving from 10,099.89 to 9,490.00. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 3 of the last 12 weeks. Relative Strength is -20.17 and has softened across the 12-week window. Market Dynamics is -0.95 on the latest week. Next-week expectancy is undecided at 54.84% based on similar historical setup states.
Industry Peers
Argentina equities in Drug Manufacturers - General
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| DJNJ3 Johnson & Johnson | BUE | 10 Jul 2026 | 1640.00 | 1640.00 | 1640.00 | 1640.00 | 0.00% |
| JNJ Johnson & Johnson | BUE | 10 Jul 2026 | 27420.00 | 28280.00 | 26620.00 | 26800.00 | -2.26% |
| BMY Bristol-Myers Squibb Company | BUE | 10 Jul 2026 | 31000.00 | 31000.00 | 29800.00 | 30060.00 | -3.03% |
| MRK Merck & Co., Inc. | BUE | 10 Jul 2026 | 39960.00 | 40780.00 | 38520.00 | 38720.00 | -3.10% |
| GSK GSK plc | BUE | 10 Jul 2026 | 21340.00 | 21340.00 | 20560.00 | 20620.00 | -3.37% |
| LLY Eli Lilly and Company | BUE | 10 Jul 2026 | 34740.00 | 35000.00 | 32880.00 | 33240.00 | -4.32% |
| GILD Gilead Sciences, Inc. | BUE | 10 Jul 2026 | 53225.00 | 56700.00 | 50575.00 | 50825.00 | -4.51% |
| AMGN Amgen Inc. | BUE | 10 Jul 2026 | 19910.00 | 19910.00 | 18830.00 | 18880.00 | -5.17% |
| ABBV AbbVie Inc. | BUE | 10 Jul 2026 | 41120.00 | 41120.00 | 38400.00 | 38720.00 | -5.84% |
| BIIB Biogen Inc. | BUE | 10 Jul 2026 | 26200.00 | 26200.00 | 23660.00 | 24000.00 | -8.40% |
| NVS Novartis AG | BUE | 10 Jul 2026 | 67200.00 | 67200.00 | 60075.00 | 60375.00 | -10.16% |
| AZN AstraZeneca PLC | BUE | 10 Jul 2026 | 80000.00 | 80000.00 | 67050.00 | 67325.00 | -15.84% |